Literature DB >> 33603733

Ribosomal Protein SA-Positive Neutrophil Elicits Stronger Phagocytosis and Neutrophil Extracellular Trap Formation and Subdues Pro-Inflammatory Cytokine Secretion Against Streptococcus suis Serotype 2 Infection.

Qiang Sun1, Na Li2, Li Jia2, Wenfei Guo1, Hexiang Jiang2, Baijun Liu2, Chuntong Bao2, Mengmeng Liu1, Jing Huang1, Liancheng Lei2,3.   

Abstract

Streptococcus suis serotype 2 (SS2), an important zoonotic pathogen that causes septicemia, arthritis, and irreversible meningitis in pigs and humans, can be transmitted to humans from pigs. S. suis causes huge economic losses to the swine industry and poses a serious threat to public health. Previously, we found that the brain tissues of mice with SS2-induced meningitis showed disrupted structural integrity and significantly enhanced polymorphonuclear neutrophil (PMN) infiltration. We showed that the brain tissues of SS2-infected mice had increased ribosomal protein SA (RPSA)-positive PMN counts. However, the inflammatory responses of RPSA+ PMNs to SS2 and their effects on the blood-brain barrier (BBB) remain unclear. Therefore, in studying the pathogenesis of SS2-induced meningitis, it is essential that we explore the functions of RPSA+ PMNs and their effects on the BBB. Herein, using flow cytometry and immunofluorescence microscopy analyses, we found that RPSA expression enhances PMN-induced phagocytosis and PMN-induced formation of neutrophil extracellular traps (NETs), which facilitate further elimination of bacteria. PMN surface expression of RPSA also alleviates local inflammation and tissue injuries by inhibiting secretion of the pro-inflammatory cytokines, TNF-α and IL-6. Moreover, the single-cell BBB model showed that RPSA disrupts BBB integrity by downregulating expression of tight junction-associated membrane proteins on PMNs. Taken together, our data suggest that PMN-surface expression of RPSA is a double-edged sword. RPSA+ PMN owns a stronger ability of bacterial cleaning and weakens inflammatory cytokines release which are useful to anti-infection, but does hurt BBB. Partly, RPSA+ PMN may be extremely useful to control the infection as a therapeutic cellular population, following novel insights into the special PMN population.
Copyright © 2021 Sun, Li, Jia, Guo, Jiang, Liu, Bao, Liu, Huang and Lei.

Entities:  

Keywords:  Streptococcus suis serotype 2; blood-brain barrier; infection; polymorphonuclear neutrophil; ribosomal protein SA

Year:  2021        PMID: 33603733      PMCID: PMC7884477          DOI: 10.3389/fimmu.2020.585399

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  65 in total

1.  Parkin induces upregulation of 40S ribosomal protein SA and posttranslational modification of cytokeratins 8 and 18 in human cervical cancer cells.

Authors:  Dae-Geun Song; Yoon Suk Kim; Byung Chul Jung; Ki-Jong Rhee; Cheol-Ho Pan
Journal:  Appl Biochem Biotechnol       Date:  2013-08-29       Impact factor: 2.926

2.  Neutrophil Elastase Damages the Pulmonary Endothelial Glycocalyx in Lipopolysaccharide-Induced Experimental Endotoxemia.

Authors:  Kodai Suzuki; Hideshi Okada; Genzou Takemura; Chihiro Takada; Ayumi Kuroda; Hirohisa Yano; Ryogen Zaikokuji; Kentaro Morishita; Hiroyuki Tomita; Kazumasa Oda; Saori Matsuo; Akihiro Uchida; Tetsuya Fukuta; So Sampei; Nagisa Miyazaki; Tomonori Kawaguchi; Takatomo Watanabe; Takahiro Yoshida; Hiroaki Ushikoshi; Shozo Yoshida; Yoichi Maekawa; Shinji Ogura
Journal:  Am J Pathol       Date:  2019-05-18       Impact factor: 4.307

Review 3.  Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions.

Authors:  Samer Kayal; Alain Charbit
Journal:  FEMS Microbiol Rev       Date:  2006-07       Impact factor: 16.408

4.  The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization.

Authors:  Carmine Selleri; Pia Ragno; Patrizia Ricci; Valeria Visconte; Nicola Scarpato; Maria Vincenza Carriero; Bruno Rotoli; Guido Rossi; Nunzia Montuori
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

5.  A region in the C-terminal domain of ribosomal protein SA required for binding of SA to the human 40S ribosomal subunit.

Authors:  Alexey A Malygin; Elena S Babaylova; Valery B Loktev; Galina G Karpova
Journal:  Biochimie       Date:  2010-12-16       Impact factor: 4.079

6.  37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake.

Authors:  Jin Woong Chung; Suk Jin Hong; Kee Jun Kim; Daniel Goti; Monique F Stins; Sooan Shin; Valina L Dawson; Ted M Dawson; Kwang Sik Kim
Journal:  J Biol Chem       Date:  2003-03-03       Impact factor: 5.157

7.  A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67kDa Laminin Receptor (LR).

Authors:  Yong Li; Dajiang Li; Jian Chen; Shuguang Wang
Journal:  Int J Biol Macromol       Date:  2016-08-27       Impact factor: 6.953

Review 8.  Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review.

Authors:  Iman Salem; Mark Kimak; Rosalynn Conic; Nicola L Bragazzi; Abdulla Watad; Mohammad Adawi; Charlie Bridgewood; Alessia Pacifico; Pierachille Santus; Maurizio Rizzi; Stephen Petrou; Delia Colombo; Marco Fiore; Paolo D M Pigatto; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2019-06-10       Impact factor: 3.411

9.  Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.

Authors:  Kerrilyn Naidoo; Sibusiso T Malindisa; Tyrone C Otgaar; Martin Bernert; Bianca Da Costa Dias; Eloise Ferreira; Uwe Reusch; Stefan Knackmuss; Melvyn Little; Stefan F T Weiss; Boitelo T Letsolo
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils.

Authors:  Su-Fang Chen; Feng-Mei Wang; Zhi-Ying Li; Feng Yu; Min Chen; Ming-Hui Zhao
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.